Market News AIOpen the app

Tango Therapeutics and Erasca have started a clinical trial to test vopimetostat and Eras-0015 for cancer treatment.

TrialRead the original at moomoo.com
Good for TNGX

Starting the Phase 1/2 study advances Tango's combination treatment toward testing in people. Safety and benefit are still unproven, but this step moves its cancer research forward.

TNGX · Tango Therapeutics

AI read · Good for TNGX

The AI's read

This gives Tango a chance to test the drug combination in people. That advances its cancer research, but the study still needs to show whether the treatment is safe and works.

Get alerts for TNGX

Follow Tango Therapeutics (TNGX) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for TNGX
Free on the App Store and Google Play, or on the web.